The invention belongs to the technical field of
chemical synthesis, and discloses a preparation method of a medical intermediate, and the name of the specific compound is 3, 3-difluoro-4-oxopiperidine-1-
carboxylic acid tert-butyl ester monohydrate. A brand new synthesis
route is provided, and the six-step synthesis method comprises the following steps: taking 2, 4-dimethoxybenzylamine as an initial
raw material, dropwise adding
ethyl acrylate at the temperature of 30-40 DEG C, and stirring for reaction to obtain an intermediate 1; continuously adding
benzotriazole, dropwise adding a 37%
formaldehyde aqueous solution, and obtaining an intermediate 2 under the condition of
room temperature; continuously adding
zinc powder, controlling the temperature of the room, dropwise adding trimethylchlorosilane and ethyl bromodifluoroacetate, and stirring and reacting at
room temperature to obtain an intermediate 3; continuously adding one of
sodium methoxide,
sodium ethoxide or
potassium tert-butoxide, and stirring at
room temperature to completely react to obtain an intermediate 4; adding a 16%
sodium hydroxide solution while stirring, heating to 95-100 DEG C, and stirring for reaction to obtain an intermediate 5; controlling the temperature to be 10-20 DEG C, dropwise adding
trifluoroacetic acid, and stirring at room temperature to react completely; and performing post-treatment on the reaction liquid to obtain a product. And a green, safe and high-yield
kilogram-level process easy for industrial production is established. A stable and cheap intermediate source is provided for innovative drugs, the yield is increased, and the competitiveness of the innovative drugs is improved.